Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease

Area of Science:

• Pediatric Gastroenterology
• Clinical Chemistry
• Inflammatory Diseases

Background:

• Inflammatory bowel disease (IBD) encompasses chronic gastrointestinal inflammation.
• Accurate and early diagnosis in children is crucial for effective management.
• Biomarkers like C-reactive protein (CRP) are often used to assess inflammation.

Purpose of the Study:

• To evaluate the utility of C-reactive protein (CRP) and routine blood tests in diagnosing newly diagnosed pediatric inflammatory bowel disease (IBD).
• To determine if CRP levels can aid in identifying IBD cases during endoscopic evaluation.
• To assess the sensitivity of CRP in detecting mild cases of ulcerative colitis.

Main Methods:

• Retrospective analysis of routine blood tests, including CRP levels, in children with newly diagnosed IBD.
• Correlation of CRP levels with endoscopic findings and diagnosis.
• Comparison of CRP levels across different IBD subtypes, including ulcerative colitis.

Main Results:

• C-reactive protein (CRP) levels were elevated in a significant portion of children with newly diagnosed inflammatory bowel disease (IBD).
• CRP evaluation assisted in identifying additional IBD patients during endoscopic procedures.
• A notable proportion of pediatric patients with mild ulcerative colitis presented with normal CRP levels.

Conclusions:

• C-reactive protein (CRP) is a valuable, though not universally definitive, biomarker in the diagnosis of pediatric inflammatory bowel disease (IBD).
• Normal CRP levels do not exclude the possibility of mild ulcerative colitis in children.
• Combined assessment of CRP with clinical and endoscopic findings improves diagnostic accuracy for pediatric IBD.